Search - tctmd.com

Displaying 521 - 540 of 635

Sort: Relevancy | Date

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Presentation TCT 2017

LAA Closure III: Postprocedure and Beyond

Presenter: Russell A. Brandwein

October 30, 2017

Presentation TCT 2017

Germany Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Thomas Walther

October 30, 2017

Presentation TCT 2017

LAA Closure II: From Consultation to Procedure

Presenter: Russell A. Brandwein, Jessica Forman

October 30, 2017

Presentation TCT 2017

Czech Republic Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Marian Branny

October 30, 2017

Presentation TCT 2017

LAA Closure I: From Referral to Consultation

Presenter: Russell A. Brandwein, Lindsay Thomas

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Presenter: Petr Kala, Jochen Wöhrle, Martin Hudec

October 30, 2017

Presentation TCT 2017

Tricuspid Valve Disease and TTV Repair and Replacement: Progress and Obstacles

Presenter: Russell A. Brandwein

October 30, 2017

Presentation TCT 2017

Mitral Valve Disease and TMV Repair and Replacement: Progress and Obstacles

Presenter: Russell A. Brandwein, Elizabeth M. Perpetua

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey V: Addressing Complications and Follow-up

Presenter: Martina Kelly Speight, Amy E. Simone

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey IV: The Hospital Experience

Presenter: Martina Kelly Speight, Sandra Lauck

October 30, 2017

Presentation TCT 2017

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Wei-Hsian Yin

October 30, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey III: Behind the Scenes

Presenter: Martina Kelly Speight, Sarah Clarke

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey II: Imaging Assessment

Presenter: Martina Kelly Speight, João L Cavalcante

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey I: Initial Evaluation

Presenter: Martina Kelly Speight, Patricia Keegan

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2017

Case Presentation 6: BTK Intervention

Presenter: Sergey A. Abugov, Juan F. Granada, Zaza Kavteladze

October 29, 2017

Presentation TCT 2017

Editorial Comment

Presenter: Sergey A. Abugov, Juan F. Granada, Susheel K. Kodali

October 29, 2017

Advertisement

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

LAA Closure III: Postprocedure and Beyond

Germany Comments: How Would I Treat This Case and Why?

LAA Closure II: From Consultation to Procedure

Czech Republic Comments: How Would I Treat This Case and Why?

LAA Closure I: From Referral to Consultation

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Tricuspid Valve Disease and TTV Repair and Replacement: Progress and Obstacles

Mitral Valve Disease and TMV Repair and Replacement: Progress and Obstacles

TAVR Patient Journey V: Addressing Complications and Follow-up

TAVR Patient Journey IV: The Hospital Experience

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

TAVR Patient Journey III: Behind the Scenes

TAVR Patient Journey II: Imaging Assessment

TAVR Patient Journey I: Initial Evaluation

Off Script: Welcome to TCT 2017 in the Mile High City

Case Presentation 6: BTK Intervention

Editorial Comment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content